Next Up Fiscal 2024 1Q Financial Results Quarterly Highlights Emily Leproust Chief Executive Officer Q&A Session Legal Disclaimers | PROPRIETARY and CONFIDENTIAL | TWIST BIOSCIENCE $77.5 M Orders Strong orders 4 1Q 2024 • Launch of Express Genes* ü FoF-enabled new product introduction 450bp oligo synthesis *Limited launch initiated November 13, 2023; full launch on January 24, 2024 ü RNA sequencing workflow Advanced library prep Growth Combined Biopharma Business Including Historical Abveris Programs | TWIS ...